GleamWall
中文EN

UTMD UTAH MEDICAL PRODUCTS INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 706698 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-9.6%
TTM net income YoY-8.4%
TTM EPS YoY-5.6%
Revenue 3-yr CAGR-12.1%
Net income 3-yr CAGR-14.3%

Margins

Gross margin57.7%
Operating margin29.9%
Net margin30.5%
FCF margin31.1%
EBITDA margin32.4%

Returns

ROE8.8%
ROA8.5%
ROIC (approx.)23.7%
Asset turnover0.28x

Leverage & solvency

Liabilities / assets4.1%
Debt / equity0.00x
Current ratio21.23x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.08x
Accruals ratio-0.7%
Payout ratio37.0%
Capex / revenue1.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q3*2026-09-302026Q2*2026-06-302026Q1*2026-03-312025Q4*2025-12-312025Q3*2025-09-302025Q2*2025-06-302025Q1*2025-03-312024Q4*2024-12-31
Income statement
Revenue$8.62M$8.53M$8.72M$9.04M$9.81M$9.95M$9.71M$9.16M
Cost of revenue$3.78M$3.77M$3.44M$3.78M$4.21M$4.36M$4.17M$3.83M
Gross profit$4.84M$4.76M$5.28M$5.26M$5.60M$5.59M$5.54M$5.32M
R&D expense$142,000$154,000$154,000$212,000$167,000$135,000$154,000$121,000
SG&A expense$1.90M$1.96M$2.56M$560,000$2.83M$2.26M$2.23M$371,000
Operating income$2.79M$2.65M$2.56M$2.44M$2.61M$3.20M$3.15M$2.93M
Pretax income$3.40M$3.29M$3.18M$3.11M$3.31M$3.84M$3.86M$3.61M
Income tax$614,000$600,000$578,000$540,000$678,000$788,000$817,000$712,000
Net income$2.79M$2.69M$2.60M$2.56M$2.63M$3.05M$3.04M$2.90M
EBITDA$3.01M$2.86M$2.78M$2.65M$2.82M$3.40M$3.35M$3.13M
EPS (basic)0.880.840.82—0.820.940.92—
EPS (diluted)0.880.840.820.800.820.940.920.86
Weighted avg. shares (diluted)3.18M3.18M3.19M—3.21M3.25M3.31M—
Balance sheet
Cash & equivalents$85.20M$87.53M$87.41M$85.76M$84.27M$82.18M$83.33M$82.98M
Receivables$3.96M$3.56M$3.64M$3.52M$3.73M$3.63M$3.94M$4.09M
Inventory$10.57M$9.00M$8.72M$7.93M$8.12M$8.23M$8.65M$8.81M
Current assets$100.63M$100.64M$100.38M$97.74M$96.53M$94.38M$96.40M$96.33M
PP&E, net$10.02M$9.63M$9.72M$9.91M$10.00M$10.26M$9.95M$9.76M
Goodwill$13.96M$13.96M$13.92M$14.05M$14.05M$14.19M$13.77M$13.58M
Intangibles$3.88M$346,000$364,000$840,000$1.39M$1.98M$2.40M$2.87M
Total assets$128.50M$124.57M$124.38M$122.54M$121.97M$120.80M$122.52M$122.54M
Current liabilities$4.74M$2.07M$3.50M$2.60M$3.01M$2.25M$4.32M$3.76M
Long-term debt$180,000$195,000$210,000$225,000——$269,000$282,000
Total debt$180,000$195,000$210,000$225,000——$269,000$282,000
Total liabilities$5.22M$2.54M$4.01M$3.27M$3.72M$3.27M$5.47M$5.11M
Shareholders' equity$123.28M$122.03M$120.37M$119.27M$118.25M$117.53M$117.05M$117.43M
Net debt-$85.02M-$87.33M-$87.20M-$85.53M——-$83.06M-$82.69M
Shares outstanding3.17M3.18M3.18M3.19M3.20M3.22M3.28M3.33M
Cash flow statement
Operating cash flow$3.50M$1.38M$3.11M$3.48M$3.88M$2.87M$4.46M$2.94M
Capital expenditure$236,000$134,000$130,000$109,000$27,000$51,000$184,000$9,000
Free cash flow$3.26M$1.25M$2.98M$3.37M$3.85M$2.82M$4.28M$2.93M
Investing cash flow-$4.28M-$134,000-$130,000-$109,000-$27,000-$51,000-$184,000-$9,000
Financing cash flow-$1.58M-$1.06M-$1.12M-$1.97M-$1.64M-$4.49M-$4.24M-$7.75M
Depreciation & amortization$217,000$210,000$211,000$212,000$209,000$205,000$200,000$200,000
Stock-based compensation$77,000$72,000$120,000$111,000$94,000$86,000$82,000$72,000
Dividends paid$987,000$987,000$989,000$977,000$988,000$1.00M$1.02M$1.04M
Share buybacks$699,000$78,000$128,000$994,000$653,000$3.49M$3.22M$6.71M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.